Covidien Celebrates its First Anniversary as an Independent Healthcare Products Company.

Worldwide celebrations mark global leader's year of robust growth following separation from Tyco International 

MANSFIELD, Mass. -- Covidien (NYSE: COV, BSX: COV) will mark its highly successful first year as an independent healthcare products company with worldwide celebrations on July 10, 2008. The Company and its 42,000 employees will commemorate the historic milestone with "Covidien@One" anniversary activities at more than 200 offices, laboratories and manufacturing facilities located in 57 countries around the world.

Covidien President and Chief Executive Officer Richard J. Meelia congratulated employees on their outstanding efforts during the Company's first year, noting "a tremendous sense of pride and excitement about what we have accomplished." Mr. Meelia told employees, "With your hard work and dedication, we expect the year ahead to bring continued strong progress as we launch major new products, execute our strategic growth initiatives and further globalize our business."

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2007 revenue of nearly $9 billion, Covidien has more than 42,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business.